Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting

Hyponatremia, SIADH, and Salt Wasting

Confirm the Type of Sodium Disturbance

Sodium concentration reflects the balance of body water and exchangeable solute rather than sodium stores alone. Measure serum osmolality and glucose, assess medications and fluids, and establish the time course. Hyperglycemia can lower measured sodium through an extracellular water shift while increasing tonicity. Severe hyperlipidemia or hyperproteinemia can cause pseudohyponatremia with some laboratory methods. Neither situation should automatically receive the same treatment as symptomatic hypotonic hyponatremia.

AVP is synthesized in hypothalamic supraoptic and paraventricular nuclei, transported to the posterior pituitary, and released in response to osmotic and nonosmotic stimuli. Renal V2 signaling increases collecting-duct aquaporin-2 insertion and water retention. Hypovolemia, pain, nausea, stress, and drugs can sustain AVP even when plasma is hypotonic. Thus a concentrated urine is evidence of impaired water excretion, not proof of SIADH by itself.

Evaluate the examination, intake and output, weight trend, kidney function, urine osmolality and sodium, recent diuretics, and adrenal and thyroid context. Do not diagnose euvolemia from one CVP or IVC image. Ventilation, right-heart function, positioning, and measurement technique affect these findings. Adrenal deficiency can mimic SIADH and may be immediately dangerous; suspected adrenal crisis requires prompt treatment rather than waiting for a perfect diagnostic profile.

SIADH Versus Salt Wasting

SIADH typically combines hypotonic hyponatremia, inappropriately concentrated urine, and clinical euvolemia after exclusion of relevant renal, endocrine, drug, and volume causes. High urine sodium is common with adequate intake, but the concentration is affected by diuretics, intake, kidney disease, and prior treatment. Brain injury, pulmonary disease, infection, malignancy, and medications can contribute. Low uric acid and urea may support the pattern without establishing it alone.

Cerebral or renal salt wasting describes renal sodium loss with extracellular volume depletion in a relevant clinical setting. Definitions and differentiation from SIADH remain debated. Proposed mechanisms include altered sympathetic signaling and natriuretic factors, but a BNP measurement does not diagnose the syndrome. Look for sustained urinary salt loss, negative balance, polyuria, hemodynamic change, and response to carefully monitored replacement while excluding other causes of volume depletion.

Both syndromes may show elevated fractional urate excretion during hyponatremia. In proposed diagnostic approaches, FEurate tends to normalize after sodium correction in SIADH and remain elevated in renal salt wasting. This is the reverse of the erroneous claim that it stays elevated only in SIADH. Renal function, timing, medications, and the limitations of the approach matter; do not use it as an infallible standalone bedside test.

Treat the Patient and the Cause

A hypovolemic patient needs appropriate volume and sodium replacement. In aSAH, volume contraction can worsen perfusion and complicate DCI risk, so avoid reflexive water restriction when it would worsen depletion. Maintain euvolemia rather than prophylactic hypervolemia. Selected mineralocorticoid treatment can reduce natriuresis, but monitor potassium, fluid balance, edema, and pressure. A sodium value alone does not mandate fludrocortisone for every patient.

For a genuinely euvolemic SIADH presentation without severe symptoms, treatment may include water-intake management, removal of causes, and selected solute or other therapies. The neurologic disease and perfusion needs affect the choice. There is no universal rule that fluid restriction is forbidden in every TBI patient. Vaptans can cause rapid aquaresis and overcorrection and are not emergency substitutes for hypertonic saline in a seizing patient. Kidney and liver function, interactions, and local expertise influence use.

Severe Symptoms: Raise Sodium Promptly but Deliberately

Seizure, severe encephalopathy, respiratory compromise, or herniation attributable to hypotonic hyponatremia requires urgent monitored treatment. Give a protocol-based 3% saline bolus, commonly 100 mL over ten minutes or 150 mL over twenty minutes depending on the selected guideline, with repeat assessment and additional boluses if needed. Do not combine two protocols into an automatic unmonitored series. Treat the airway and seizures in parallel.

The early goal is generally a sodium increase of approximately 4–6 mEq/L with clinical improvement, not immediate correction to normal or high-normal sodium. One bolus does not guarantee that rise, and no fixed 50% reduction in brain water can be promised. Recheck sodium frequently, follow urine output, account for all fluids and potassium replacement, and change the plan as symptoms and measurements evolve. Once immediate danger improves, slow correction according to duration and osmotic demyelination risk.

Prevent and Rescue Overcorrection

Chronic adaptation reduces brain osmoles, making rapid sodium elevation dangerous. Important ODS risks include very low starting sodium, alcohol use disorder, malnutrition, hypokalemia, and advanced liver disease. In high-risk patients, target 4–6 mEq/L per day and avoid a rise above 8 in any 24-hour period. Other guideline limits vary, and a conservative plan can be selected when duration or risk is uncertain. These are cumulative limits across treatment transitions, not a fresh allowance at midnight.

A sudden water diuresis can accelerate correction after volume or cortisol replacement even when hypertonic saline has stopped. If sodium is rising excessively, stop the driver, obtain urgent expert input, and consider protocol-based desmopressin and electrolyte-free water to halt aquaresis and relower safely. Dose and fluid rate depend on the measured trajectory and monitoring; an identical high-rate D5W infusion is not appropriate for every patient.

ODS can appear days after initial improvement with dysarthria, dysphagia, movement abnormalities, weakness, or altered consciousness. MRI findings may lag, and not every case has the same pontine pattern. Prevention and careful response to overcorrection are central. Document the starting sodium, elapsed intervals, risk factors, total rise, and rescue plan at each handoff.

Source: 2024 expert review of hyponatremia treatment safeguards and 2023 aSAH guideline summary.

Decision Review